Now, a directory of blood donorsTimes of IndiaThe survey claimed that there are negative perceptions about blood donation in the district which are termed as major reasons behind acute shortage of voluntary donors. While efforts are underway to equip b…
Grieving dads help push for organ donor billCityNews“The two of us go around the world talking about organ donation, but we've never met. And our hope is that by bringing it to people's attention, that we'll save a lot of lives.” The tw…
Knowledge transplantShepparton NewsDr Hodgson last year finished studying his PhD in xenotransplantation , the transferring of living cells, organs or tissues from one species to another. Xenotransplantation was the topic of his talk to Goulburn Valley…
Lung disorder drug regimen found harmfulVanderbilt University NewsIt is important to note the combination drug therapy has not been shown to be dangerous for treating other diseases, such as connective tissue diseases, including rheumatoid arthritis, o…
Chris' TearsAnnals of Internal MedicineRenal cancer required a nephrectomy. Recurrence in the other kidney required a second nephrectomy and chronic hemodialysis. A stroke left him hemiparetic and aphasic but cognitively intact. He became frustrate…
One small app, big difference in organ donationWKYC-TVThe sign/poster also has information for those without smart phones on how to connect to "Just One For Mom." Her hope is the QR code will get scanned by just the right person, a match. Or …
Philadelphia MagazinePenn docs perform double hand transplantBizjournals.comPenn officials said a team of 30 members — 12 surgeons, three anesthesiologists and 15 nurses — performed the 11-and-a-half hour double transplant procedure — called a va…
The Rituximab Story: not evidence for XMRV and NOT a potential autism therapyLeft Brain/Right BrainUnfortunately, in an attempt to revive the XMRV/autism link, Kent Heckenlively of the Age of Autism blog is creating a new, dangerous conclusion: perhaps…
Study Finds Early And Delayed Stem Cell Transplants Have Comparable Efficacy …The Myeloma BeaconResults of a recent analysis suggest that newly diagnosed multiple myeloma patients receiving Revlimid or thalidomide as initial therapy have similar prog…
Daclizumab Shows Promise in Multiple Sclerosis TrialFamily Practice News Digital NetworkAMSTERDAM – Daclizumab reduced the rate of relapse and the rate of disability progression in patients with relapsing-remitting multiple sclerosis in a 1-year, pla…